Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?

Introduction SARS-CoV-2 was first detected in December 2019 in the Chinese city of Wuhan and has since spread across the world. At present, the virus has infected over 1.7 million people and caused over 100 000 deaths worldwide. Research is currently focused on understanding the acute infection and...

Descripción completa

Detalles Bibliográficos
Autores: Serrano-Castro, P. J., Estivill-Torrús, G., Cabezudo-García, P., Reyes-Bueno, J. A., Ciano Petersen, N., Aguilar-Castillo, M. J., Jiménez Hernández, María Dolores, Rodríguez de Fonseca, F.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/146326
Acceso en línea:https://hdl.handle.net/11441/146326
https://doi.org/10.1016/j.nrl.2020.04.002
Access Level:acceso abierto
Palabra clave:COVID-19
SARS-CoV-2
Neuroinflammation
Neurodegenerative diseases
Neuropsychiatric diseases
Cytokine storm
Neuroinflamación
Enfermedades neurodegenerativas
Enfermedades neuropsiquiátricas
Tormenta de citoquinas
id ES_e602fcbbfaa4ca38b8e757a6bb26a079
oai_identifier_str oai:idus.us.es:11441/146326
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas: ¿una pandemia demorada?
title Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
spellingShingle Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
Serrano-Castro, P. J.
COVID-19
SARS-CoV-2
Neuroinflammation
Neurodegenerative diseases
Neuropsychiatric diseases
Cytokine storm
Neuroinflamación
Enfermedades neurodegenerativas
Enfermedades neuropsiquiátricas
Tormenta de citoquinas
title_short Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
title_full Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
title_fullStr Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
title_full_unstemmed Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
title_sort Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
dc.creator.none.fl_str_mv Serrano-Castro, P. J.
Estivill-Torrús, G.
Cabezudo-García, P.
Reyes-Bueno, J. A.
Ciano Petersen, N.
Aguilar-Castillo, M. J.
Jiménez Hernández, María Dolores
Rodríguez de Fonseca, F.
author Serrano-Castro, P. J.
author_facet Serrano-Castro, P. J.
Estivill-Torrús, G.
Cabezudo-García, P.
Reyes-Bueno, J. A.
Ciano Petersen, N.
Aguilar-Castillo, M. J.
Jiménez Hernández, María Dolores
Rodríguez de Fonseca, F.
author_role author
author2 Estivill-Torrús, G.
Cabezudo-García, P.
Reyes-Bueno, J. A.
Ciano Petersen, N.
Aguilar-Castillo, M. J.
Jiménez Hernández, María Dolores
Rodríguez de Fonseca, F.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Cirugía
dc.subject.none.fl_str_mv COVID-19
SARS-CoV-2
Neuroinflammation
Neurodegenerative diseases
Neuropsychiatric diseases
Cytokine storm
Neuroinflamación
Enfermedades neurodegenerativas
Enfermedades neuropsiquiátricas
Tormenta de citoquinas
topic COVID-19
SARS-CoV-2
Neuroinflammation
Neurodegenerative diseases
Neuropsychiatric diseases
Cytokine storm
Neuroinflamación
Enfermedades neurodegenerativas
Enfermedades neuropsiquiátricas
Tormenta de citoquinas
description Introduction SARS-CoV-2 was first detected in December 2019 in the Chinese city of Wuhan and has since spread across the world. At present, the virus has infected over 1.7 million people and caused over 100 000 deaths worldwide. Research is currently focused on understanding the acute infection and developing effective treatment strategies. In view of the magnitude of the epidemic, we conducted a speculative review of possible medium- and long-term neurological consequences of SARS-CoV-2 infection, with particular emphasis on neurodegenerative and neuropsychiatric diseases of neuroinflammatory origin, based on the available evidence on neurological symptoms of acute SARS-CoV-2 infection. Development We systematically reviewed the available evidence about the pathogenic mechanisms of SARS-CoV-2 infection, the immediate and lasting effects of the cytokine storm on the central nervous system, and the consequences of neuroinflammation for the central nervous system. Conclusions SARS-CoV-2 is a neuroinvasive virus capable of triggering a cytokine storm, with persistent effects in specific populations. Although our hypothesis is highly speculative, the impact of SARS-CoV-2 infection on the onset and progression of neurodegenerative and neuropsychiatric diseases of neuroinflammatory origin should be regarded as the potential cause of a delayed pandemic that may have a major public health impact in the medium to long term. Cognitive and neuropsychological function should be closely monitored in COVID-19 survivors.
publishDate 2020
dc.date.none.fl_str_mv 2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/11441/146326
https://doi.org/10.1016/j.nrl.2020.04.002
url https://hdl.handle.net/11441/146326
https://doi.org/10.1016/j.nrl.2020.04.002
dc.language.none.fl_str_mv Español
Inglés
language_invalid_str_mv Español
Inglés
dc.relation.none.fl_str_mv Neurología, 35 (4), 245-251.
https://www.sciencedirect.com/science/article/pii/S0213485320300670?via%3Dihub
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:idUS. Depósito de Investigación de la Universidad de Sevilla
instname:Universidad de Sevilla (US)
instname_str Universidad de Sevilla (US)
reponame_str idUS. Depósito de Investigación de la Universidad de Sevilla
collection idUS. Depósito de Investigación de la Universidad de Sevilla
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422730163519488
spelling Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas: ¿una pandemia demorada?Serrano-Castro, P. J.Estivill-Torrús, G.Cabezudo-García, P.Reyes-Bueno, J. A.Ciano Petersen, N.Aguilar-Castillo, M. J.Jiménez Hernández, María DoloresRodríguez de Fonseca, F.COVID-19SARS-CoV-2NeuroinflammationNeurodegenerative diseasesNeuropsychiatric diseasesCytokine stormNeuroinflamaciónEnfermedades neurodegenerativasEnfermedades neuropsiquiátricasTormenta de citoquinasIntroduction SARS-CoV-2 was first detected in December 2019 in the Chinese city of Wuhan and has since spread across the world. At present, the virus has infected over 1.7 million people and caused over 100 000 deaths worldwide. Research is currently focused on understanding the acute infection and developing effective treatment strategies. In view of the magnitude of the epidemic, we conducted a speculative review of possible medium- and long-term neurological consequences of SARS-CoV-2 infection, with particular emphasis on neurodegenerative and neuropsychiatric diseases of neuroinflammatory origin, based on the available evidence on neurological symptoms of acute SARS-CoV-2 infection. Development We systematically reviewed the available evidence about the pathogenic mechanisms of SARS-CoV-2 infection, the immediate and lasting effects of the cytokine storm on the central nervous system, and the consequences of neuroinflammation for the central nervous system. Conclusions SARS-CoV-2 is a neuroinvasive virus capable of triggering a cytokine storm, with persistent effects in specific populations. Although our hypothesis is highly speculative, the impact of SARS-CoV-2 infection on the onset and progression of neurodegenerative and neuropsychiatric diseases of neuroinflammatory origin should be regarded as the potential cause of a delayed pandemic that may have a major public health impact in the medium to long term. Cognitive and neuropsychological function should be closely monitored in COVID-19 survivors.Introducción La infección por el coronavirus SARS-CoV-2 originada en diciembre de 2019 en la región china de Wuhan ha adquirido proporciones pandémicas. A día de hoy ha ocasionado más de 1,7 millones de contagios y más de 100.000 muertes en todo el mundo. La investigación científica actual se centra en el mejor conocimiento de la infección aguda y de sus estrategias terapéuticas. Dada la magnitud de la epidemia, planteamos una revisión especulativa sobre las posibles consecuencias en patología neurológica a medio/largo plazo, con especial atención a enfermedades neurodegenerativas y neuropsiquiátricas con base neuroinflamatoria, teniendo en cuenta la evidencia directa de afectación neurológica a causa de la infección aguda. Desarrollo Revisamos de forma sistemática lo conocido sobre los mecanismos patogénicos de la infección por SARS-CoV-2, la repercusión de la tormenta de citoquinas sobre el sistema nervioso central y su persistencia en el tiempo y las consecuencias que la neuroinflamación puede tener sobre el sistema nervioso central. Conclusiones El SARS-CoV-2 es un virus neuroinvasivo capaz de provocar una tormenta de citoquinas que podría convertirse en persistente en población seleccionada. Aunque nuestra hipótesis tiene alto componente especulativo, la repercusión que esta situación puede tener en la puesta en marcha y progresión de enfermedades neurodegenerativas y neuropsiquiátricas con base neuroinflamatoria debe ser considerada como posible germen de una pandemia demorada que podría tener un gran impacto en salud pública a medio o largo plazo. Se hace necesario un estrecho seguimiento de la salud cognitiva y neuropsiquiátrica de los pacientes supervivientes a infección COVID-19.ElsevierCirugía2020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfapplication/pdfhttps://hdl.handle.net/11441/146326https://doi.org/10.1016/j.nrl.2020.04.002reponame:idUS. Depósito de Investigación de la Universidad de Sevillainstname:Universidad de Sevilla (US)EspañolInglésNeurología, 35 (4), 245-251.https://www.sciencedirect.com/science/article/pii/S0213485320300670?via%3Dihubinfo:eu-repo/semantics/openAccessoai:idus.us.es:11441/1463262026-06-17T12:51:07Z
score 15,301629